JP2021520849A5 - - Google Patents

Info

Publication number
JP2021520849A5
JP2021520849A5 JP2021504566A JP2021504566A JP2021520849A5 JP 2021520849 A5 JP2021520849 A5 JP 2021520849A5 JP 2021504566 A JP2021504566 A JP 2021504566A JP 2021504566 A JP2021504566 A JP 2021504566A JP 2021520849 A5 JP2021520849 A5 JP 2021520849A5
Authority
JP
Japan
Prior art keywords
amino acid
tumor antigen
acid sequence
seq
population
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021504566A
Other languages
English (en)
Japanese (ja)
Other versions
JP7549826B2 (ja
JP2021520849A (ja
Filing date
Publication date
Priority claimed from PCT/CN2018/082947 external-priority patent/WO2019196088A1/en
Application filed filed Critical
Publication of JP2021520849A publication Critical patent/JP2021520849A/ja
Publication of JP2021520849A5 publication Critical patent/JP2021520849A5/ja
Priority to JP2024046768A priority Critical patent/JP2024069663A/ja
Application granted granted Critical
Publication of JP7549826B2 publication Critical patent/JP7549826B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021504566A 2018-04-13 2019-04-12 腫瘍特異的t細胞受容体を得る方法 Active JP7549826B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024046768A JP2024069663A (ja) 2018-04-13 2024-03-22 腫瘍特異的t細胞受容体を得る方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNPCT/CN2018/082947 2018-04-13
PCT/CN2018/082947 WO2019196088A1 (en) 2018-04-13 2018-04-13 Methods of obtaining tumor-specific t cell receptors
PCT/CN2019/082408 WO2019196924A1 (en) 2018-04-13 2019-04-12 Methods of obtaining tumor-specific t cell receptors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024046768A Division JP2024069663A (ja) 2018-04-13 2024-03-22 腫瘍特異的t細胞受容体を得る方法

Publications (3)

Publication Number Publication Date
JP2021520849A JP2021520849A (ja) 2021-08-26
JP2021520849A5 true JP2021520849A5 (cg-RX-API-DMAC7.html) 2022-04-20
JP7549826B2 JP7549826B2 (ja) 2024-09-12

Family

ID=68163041

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021504566A Active JP7549826B2 (ja) 2018-04-13 2019-04-12 腫瘍特異的t細胞受容体を得る方法
JP2024046768A Pending JP2024069663A (ja) 2018-04-13 2024-03-22 腫瘍特異的t細胞受容体を得る方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024046768A Pending JP2024069663A (ja) 2018-04-13 2024-03-22 腫瘍特異的t細胞受容体を得る方法

Country Status (6)

Country Link
US (6) US11390659B2 (cg-RX-API-DMAC7.html)
EP (1) EP3775168A4 (cg-RX-API-DMAC7.html)
JP (2) JP7549826B2 (cg-RX-API-DMAC7.html)
KR (1) KR102805266B1 (cg-RX-API-DMAC7.html)
CN (4) CN113185602B (cg-RX-API-DMAC7.html)
WO (2) WO2019196088A1 (cg-RX-API-DMAC7.html)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016145578A1 (en) 2015-03-13 2016-09-22 Syz Cell Therapy Co. Methods of cancer treatment using activated t cells
WO2019183924A1 (en) 2018-03-30 2019-10-03 Syz Cell Therapy Co. Improved multiple antigen specific cell therapy methods
WO2019196088A1 (en) 2018-04-13 2019-10-17 Syz Cell Therapy Co. Methods of obtaining tumor-specific t cell receptors
WO2019196087A1 (en) 2018-04-13 2019-10-17 Syz Cell Therapy Co. Methods of cancer treatment using tumor antigen-specific t cells
CN116298309B (zh) 2018-08-13 2024-04-02 根路径基因组学公司 成对的二分免疫受体多核苷酸的高通量克隆及其应用
MX2021012207A (es) 2019-04-05 2021-12-10 Rootpath Genomics Inc Composiciones y métodos para ensamblaje de genes del receptor de linfocitos t.
JP2022535006A (ja) * 2019-05-31 2022-08-04 モデルナティエックス インコーポレイテッド 増殖t細胞アッセイ
US20210040558A1 (en) * 2019-07-15 2021-02-11 Neogene Therapeutics B.V. Method to isolate tcr genes
EP4061487A4 (en) * 2019-11-19 2023-12-20 Rootpath Genomics, Inc. COMPOSITIONS AND METHODS FOR IDENTIFYING T CELL RECEPTOR
US12612444B2 (en) 2019-11-26 2026-04-28 University of Pittsburgh—of the Commonwealth System of Higher Education T cell receptors targeting mutations in RNA splicing factors
EP4100051A2 (en) * 2020-02-07 2022-12-14 ISA Pharmaceuticals B.V. Treatment of hpv-related diseases
CN111234005B (zh) * 2020-03-13 2022-11-29 中国医学科学院皮肤病医院(中国医学科学院皮肤病研究所) 氨苯砜药物超敏反应性t细胞受体及其用途
IL301543A (en) * 2020-09-24 2023-05-01 Medigene Immunotherapies Gmbh Prame specific t cell receptors and uses thereof
JP2024526836A (ja) * 2021-07-19 2024-07-19 ボード オブ リージェンツ,ザ ユニバーシティ オブ テキサス システム Fanci、rad51、およびpbk抗原を標的とするペプチドおよび操作されたt細胞受容体ならびに使用の方法
WO2023049733A2 (en) * 2021-09-21 2023-03-30 The University Of Chicago Methods and composition using patient-derived autologous neoantigens for treating cancer
CN116063511B (zh) * 2021-09-30 2023-10-03 北京可瑞生物科技有限公司 抗原结合蛋白及其应用
US20250025499A1 (en) * 2021-11-02 2025-01-23 Fred Hutchinson Cancer Center T cell immunotherapy for hematologic malignancies having an sf3b1 mutation
CN119677842A (zh) * 2022-03-17 2025-03-21 科士华(南京)生物技术有限公司 人工合成肿瘤浸润淋巴细胞
US20260166144A1 (en) * 2022-04-07 2026-06-18 Carsgen Life Sciences Co., Ltd. Chimeric polypeptide and use thereof
CN116063458A (zh) * 2022-04-27 2023-05-05 恒瑞源正(广州)生物科技有限公司 Mage-a1特异性t细胞受体及其用途
AU2023269389A1 (en) * 2022-05-10 2024-12-19 Geneos Therapeutics, Inc. Individualized cancer epitopes and methods of using the same
CN114920824B (zh) * 2022-05-27 2023-12-05 重庆医科大学 Tcr或其抗原结合片段及其应用
EP4739702A1 (en) * 2023-07-07 2026-05-13 The University Of Hong Kong Convergent recombination-derived hepatocellular carcinoma-specific tcrs and applications thereof
CN117567595B (zh) * 2024-01-17 2024-05-14 恒瑞源正(广州)生物科技有限公司 Mage-a4特异性t细胞受体及其用途
CN120518771A (zh) * 2024-02-20 2025-08-22 上海信谱生物医药科技有限公司 一种识别kras突变的t细胞受体及其编码序列
WO2025193663A2 (en) * 2024-03-11 2025-09-18 Affini-T Therapeutics, Inc. Compositions and methods for treating neoplasia
CN119613530B (zh) * 2024-12-13 2025-09-05 华中科技大学 一种靶向肝癌细胞甲胎蛋白抗原肽与hla-a24复合物的特异性tcr分子、tcr-t细胞及制备与应用

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5399346A (en) 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
EP1235842A4 (en) 1999-10-15 2003-04-23 Univ Massachusetts Rna interference pathway genes as tools for targeted genetic interference
US6326193B1 (en) 1999-11-05 2001-12-04 Cambria Biosciences, Llc Insect control agent
WO2001096584A2 (en) 2000-06-12 2001-12-20 Akkadix Corporation Materials and methods for the control of nematodes
WO2002000692A2 (en) 2000-06-28 2002-01-03 Genetics Institute, Llc. Pd-l2 molecules: pd-1 ligands and uses therefor
CN1609197A (zh) * 2003-10-17 2005-04-27 上海普泛生物科技有限公司 一种用于发现肿瘤特异性抗原和肿瘤特异性抗原决定簇的高产率逆反免疫法
US20090304679A1 (en) * 2004-05-27 2009-12-10 Weidanz Jon A Antibodies as T cell receptor mimics, methods of production and uses thereof
AU2006249640C1 (en) * 2005-04-08 2016-10-13 Coimmune, Inc. Dendritic cell compositions and methods
EP1795599A1 (en) * 2005-12-09 2007-06-13 Schuler, Gerold, Prof. Dr. Methods for generating antigen-specific effector T cells
EP2468763B1 (en) * 2007-05-31 2014-06-18 Academisch Ziekenhuis Leiden h.o.d.n. LUMC HPV epitopes targeted by T cells infiltrating cervical malignancies for use in vaccines
AU2008323853B8 (en) 2007-11-08 2014-07-24 Beth Israel Deaconess Medical Center Stimulation of anti-tumor immunity using dendritic cell/tumor cell fusions and anti-CD3/CD28
DK2271767T3 (en) 2008-04-03 2016-08-29 Cb Biotechnologies Inc Amplikonredning-multiplex polymerase chain reaction for the amplification of multiple target
EP2258719A1 (en) * 2009-05-19 2010-12-08 Max-Delbrück-Centrum für Molekulare Medizin (MDC) Multiple target T cell receptor
EP3144673B1 (en) * 2010-05-06 2019-07-10 Adaptive Biotechnologies Corporation Monitoring lymphoid neoplasm status using clonotype profiles
ES2635335T3 (es) 2010-09-20 2017-10-03 Biontech Cell & Gene Therapies Gmbh Receptores de células T específicos de antígeno y epítopos de células T
US9187534B2 (en) * 2011-03-11 2015-11-17 Universite De Geneve Multi-epitopic vaccine
US9345770B2 (en) * 2011-11-16 2016-05-24 University of Pittsburgh—of the Commonwealth System of Higher Education Immunogenic tumor associated stromal cell antigen peptides and methods of their use
JP6309209B2 (ja) * 2013-05-31 2018-04-11 国立研究開発法人国立国際医療研究センター 血管平滑筋細胞の増殖を抑制する血管内皮細胞の検出方法
CN110511960B (zh) * 2013-07-15 2023-05-23 美国卫生和人力服务部 抗人乳头瘤病毒16 e6 t细胞受体
CN105452448B (zh) 2013-07-15 2020-07-28 美国卫生和人力服务部 制备抗人乳头瘤病毒抗原的t细胞的方法
SG11201702191YA (en) 2014-09-17 2017-04-27 Univ Johns Hopkins Reagents and methods for identifying, enriching, and/or expanding antigen-specific t cells
CN104593325A (zh) * 2014-12-09 2015-05-06 深圳源正细胞医疗技术有限公司 诱导dc成熟并分泌高浓度促炎因子的方法
WO2016145578A1 (en) 2015-03-13 2016-09-22 Syz Cell Therapy Co. Methods of cancer treatment using activated t cells
DK3271382T3 (da) * 2015-03-16 2020-05-04 Max Delbrueck Centrum Fuer Molekulare Medizin Helmholtz Gemeinschaft Fremgangsmåde til detektion af nye immunogene T-celleepitoper og isolering af nye antigenspecifikke T-cellereceptorer ved hjælp af et MHC-cellebibliotek
US20180171294A1 (en) 2015-03-26 2018-06-21 The Trustees Of The University Of Pennsylvania In vitro artificial lymph node method for sensitization and expansion of t cells for therapy and epitope mapping
GB201604492D0 (en) * 2016-03-16 2016-04-27 Immatics Biotechnologies Gmbh Transfected t-cells and t-cell receptors for use in immunotherapy against cancers
US20170319638A1 (en) * 2016-05-06 2017-11-09 Virttu Biologics Limited Treatment of cancer
CN109803674A (zh) * 2016-06-10 2019-05-24 Io生物技术公司 Calr和jak2疫苗组合物
US9642906B2 (en) * 2016-09-16 2017-05-09 Baylor College Of Medicine Generation of HPV-specific T-cells
CN106645677B (zh) * 2016-11-15 2019-08-09 恒瑞源正(上海)生物科技有限公司 体外检测肿瘤新生抗原特异性t细胞的方法、试剂盒以及肿瘤疫苗
MD3551221T2 (ro) * 2016-12-08 2022-04-30 Immatics Biotechnologies Gmbh Noi receptori de celule T și imunoterapie cu utilizarea acestora
WO2019183924A1 (en) 2018-03-30 2019-10-03 Syz Cell Therapy Co. Improved multiple antigen specific cell therapy methods
WO2019196088A1 (en) 2018-04-13 2019-10-17 Syz Cell Therapy Co. Methods of obtaining tumor-specific t cell receptors
WO2019196087A1 (en) 2018-04-13 2019-10-17 Syz Cell Therapy Co. Methods of cancer treatment using tumor antigen-specific t cells

Similar Documents

Publication Publication Date Title
Zander et al. CD4+ T cell help is required for the formation of a cytolytic CD8+ T cell subset that protects against chronic infection and cancer
JP2018512380A5 (cg-RX-API-DMAC7.html)
JP2024041873A5 (cg-RX-API-DMAC7.html)
CN114072516B (zh) 经修饰的腺病毒
KR102629590B1 (ko) 암을 치료하기 위한 방법
Lutz Therapeutic potential of semi-mature dendritic cells for tolerance induction
JP2019531744A5 (cg-RX-API-DMAC7.html)
JP2024038503A5 (cg-RX-API-DMAC7.html)
RU2017134270A (ru) Способы лечения рака с применением активированных t-клеток
JP2016525881A5 (cg-RX-API-DMAC7.html)
JP2020516238A5 (cg-RX-API-DMAC7.html)
JP2017524337A5 (cg-RX-API-DMAC7.html)
Welten et al. Memory CD 8 T cell inflation vs tissue‐resident memory T cells: Same patrollers, same controllers?
US20230357718A1 (en) Methods and materials for expanding antigen-specific t cells in culture
JP2022538609A5 (cg-RX-API-DMAC7.html)
US20180078627A1 (en) Method for antigen loading of dendritic cells and vaccine
JP2022524882A (ja) 養子移入療法(Adoptive transfer therapies)におけるTリンパ球及びNK細胞の拡大増殖及び分化のための方法
JP2024538129A5 (cg-RX-API-DMAC7.html)
CN111315401A (zh) 细菌疫苗
Xu et al. Peptide-MHC–targeted retroviruses enable in vivo expansion and gene delivery to tumor-specific T cells
JP2022500034A5 (cg-RX-API-DMAC7.html)
EP1697502A2 (fr) Methodes d identification et de preparation de lymphocytes t regulateurs/suppresseurs, compositions et utilisations
JP7416629B2 (ja) 免疫応答を増強するための物質および方法
CN117050159A (zh) 靶向滑膜肉瘤syt-ssx融合突变的tcr-t细胞、tcr分子及制备方法和应用
Reinscheid et al. Acute and chronic infections drive distinct trajectories in human memory CD4+ T cell formation